These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10597881)

  • 1. GH, IGFBP-1, and IGFBP-3 response to oral glucose tolerance test in perimenopausal women: no influence of body mass index.
    Bernardi F; Petraglia F; Seppälä M; Spinetti A; Bertolini S; Driul L; Ferdeghini M; Genazzani AR
    Maturitas; 1999 Oct; 33(2):163-9. PubMed ID: 10597881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations.
    Bernardi F; Petraglia F; Seppala M; Spinetti A; Bertolini S; Ferdeghini M; Genazzani AR
    Hum Reprod; 1998 Feb; 13(2):279-84. PubMed ID: 9557822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of chronic Naltrexone treatment on growth hormone and insulin secretion in obese subjects.
    De Marinis L; Mancini A; Valle D; Bianchi A; De Luca AM; Fulghesu AM; Villa P; Mancuso S; Lanzone A
    Int J Obes Relat Metab Disord; 1997 Nov; 21(11):1076-81. PubMed ID: 9368834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF-I without significant deterioration in glucose tolerance.
    Bülow B; Erfurth EM
    Clin Endocrinol (Oxf); 1999 Jan; 50(1):45-55. PubMed ID: 10341855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea.
    Laughlin GA; Dominguez CE; Yen SS
    J Clin Endocrinol Metab; 1998 Jan; 83(1):25-32. PubMed ID: 9435412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependent changes in body composition in postmenopausal Japanese women: relationship to growth hormone secretion as well as serum levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.
    Sugimoto T; Nakaoka D; Nasu M; Kanzawa M; Sugishita T; Chihara K
    Eur J Endocrinol; 1998 Jun; 138(6):633-9. PubMed ID: 9678529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.
    Vittone J; Blackman MR; Busby-Whitehead J; Tsiao C; Stewart KJ; Tobin J; Stevens T; Bellantoni MF; Rogers MA; Baumann G; Roth J; Harman SM; Spencer RG
    Metabolism; 1997 Jan; 46(1):89-96. PubMed ID: 9005976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding protein (IGFBP)-1, and IGFBP-3 levels.
    Cano A; Castelo-Branco C; Tarín JJ
    Fertil Steril; 1999 Feb; 71(2):261-7. PubMed ID: 9988395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth.
    Kajantie E; Fall CH; Seppälä M; Koistinen R; Dunkel L; Ylihärsilä H; Osmond C; Andersson S; Barker DJ; Forsén T; Holt RI; Phillips DI; Eriksson J
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1059-65. PubMed ID: 12629086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelationships of spontaneous growth hormone axis activity, body fat, and serum lipids in healthy elderly women and men.
    O'Connor KG; Harman SM; Stevens TE; Jayme JJ; Bellantoni MF; Busby-Whitehead MJ; Christmas C; Münzer T; Tobin JD; Roy TA; Cottrell E; St Clair C; Pabst KM; Blackman MR
    Metabolism; 1999 Nov; 48(11):1424-31. PubMed ID: 10582552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.
    De Marinis L; Bianchi A; Mancini A; Gentilella R; Perrelli M; Giampietro A; Porcelli T; Tilaro L; Fusco A; Valle D; Tacchino RM
    J Clin Endocrinol Metab; 2004 Jan; 89(1):174-80. PubMed ID: 14715846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating IGF binding protein-1 is inversely associated with leptin in non-obese men and obese postmenopausal women.
    Söderberg S; Ahrén B; Eliasson M; Dinesen B; Brismar K; Olsson T
    Eur J Endocrinol; 2001 Mar; 144(3):283-90. PubMed ID: 11248749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential impact of simple childhood obesity on the components of the growth hormone-insulin-like growth factor (IGF)-IGF binding proteins axis.
    Ballerini MG; Ropelato MG; Domené HM; Pennisi P; Heinrich JJ; Jasper HG
    J Pediatr Endocrinol Metab; 2004 May; 17(5):749-57. PubMed ID: 15237710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity.
    Attia N; Tamborlane WV; Heptulla R; Maggs D; Grozman A; Sherwin RS; Caprio S
    J Clin Endocrinol Metab; 1998 May; 83(5):1467-71. PubMed ID: 9589640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lowered ghrelin levels in acromegaly—normalization after treatment].
    Kozakowski J; Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone and insulin-like growth factor binding protein-1 responses to oral glucose in patients with primary hyperparathyroidism.
    Díez JJ; Grande C; Méndez J; González-Gancedo P; Iglesias P
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):27-34. PubMed ID: 16817815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.